# To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

> **NCT01381341** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 13 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** linifanib

## Key facts

- **NCT ID:** NCT01381341
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381341, "To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01381341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*